�The American Society of
Hematology (ASH), the world's largest professional society of blood
specialists, will honour three scientists who bear made significant
contributions to the savvy of hematologic diseases.
At the 2008 ASH Annual Meeting, Clara D. Bloomfield, M.D., of the Ohio
State University in Columbus, OH, will be presented with the Henry M.
Stratton Medal, intended to honor an individual whose well-recognized
contributions to haematology have taken place over a stop of several
years. Dr. Bloomfield will receive this award for her noteworthy
achievements in the surface area of hematologic malignancies, specially acute
myelogenous leukemia, for more than three decades. Dr Bloomfield has been a
major contributor to the savvy of the biology of these diseases and
the practical use of biologic information in diagnosis, classification, and
determinant prognosis and selection of curative therapeutical approaches.
Kenneth Anderson, M.D., of the Dana-Farber Cancer Institute in Boston,
MA, volition be presented with the William Dameshek Prize, awarded to an
individual world Health Organization has made a late outstanding contribution to the field. Dr.
Anderson will be recognized for his contributions to the treatment of
myeloma. He has advance the field by establishing a new paradigm focussed
not merely on the malignant cell, but too on the microenvironment for the
designation of molecularly-targeted therapies. His rapid translations of
his pre-clinical discoveries into form I-III trials have considerably
improved the clinical final result for myeloma patients.
Robert Kyle, M.D., of the Mayo Clinic in Rochester, MN, will be
presented with the Wallace H. Coulter Award for Lifetime Achievement in
Hematology, which was established in 2007 to honor individuals who receive
made a lifelong committedness to the specialty and whose contributions have
had a major impact on education, research, and/or practice. Dr. Kyle will
receive the laurels for his contributions to the field of study of multiple myeloma,
monoclonal antibody gammopathies, amyloidosis, and related to plasma-cell disorders.
Throughout his 50-year career as a physician-researcher, educator, and
consultant, he has focused on defining these diseases, understanding their
pathogenesis, demonstration, and prognosis, and design and evaluating
therapeutic approaches. In add-on, he has authored more than a thousand
publications has trained more than 200 practicing hematologists.
These awards are named after notable figures in the Society's history
and testament be awarded during the 50th ASH Annual Meeting in December at the
Moscone Center in San Francisco. Dr. Kyle will be presented with his laurels
prior to the Plenary Scientific Session on Sunday, December 7, at 1:30 p.m.
EST. Drs. Bloomfield and Anderson will be presented with their awards at
the Presidential Symposium to be held on Tuesday, December 9, at 9:30 a.m.
For the complete annual meeting schedule and additional information, please
visit hypertext transfer protocol://www.haematology.org/meetings/2008.
The American Society of Hematology is the world's
largest professional
